Merck Research and Development Expenses 2010-2025 | MRK

Merck research and development expenses for the twelve months ending March 31, 2025 were $17.567B, a 41.92% decline year-over-year.

  • Merck annual research and development expenses for 2024 were $17.938B, a 41.25% decline from 2023.
  • Merck annual research and development expenses for 2023 were $30.531B, a 125.35% increase from 2022.
  • Merck annual research and development expenses for 2022 were $13.548B, a 10.64% increase from 2021.

Merck Research and Development Expenses 2010-2025 | MRK

  • Merck annual research and development expenses for 2024 were $17.938B, a 41.25% decline from 2023.
  • Merck annual research and development expenses for 2023 were $30.531B, a 125.35% increase from 2022.
  • Merck annual research and development expenses for 2022 were $13.548B, a 10.64% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$796.4B
Johnson & Johnson (JNJ)$379.5B
AbbVie (ABBV)$306B
Novo Nordisk (NVO)$260.6B
Roche Holding AG (RHHBY)$248.1B
Novartis AG (NVS)$234.2B
Sanofi (SNY)$128.6B
Pfizer (PFE)$125.6B
Bayer (BAYRY)$23.7B
Innoviva (INVA)$1.1B